Recent Posts - page 2
-
Winter T3 loss: Why it matters to thyroid patients
It’s April. You’re a thyroid-hormone treated person with a thyroid disability on a fixed budget of thyroid hormone. Have you been feeling hypothyroid in the past few months? If so, you’re not alone. If not, thank your thyroid, or your… Read More ›
-
Meet deiodinase type 1 (D1): The philanthropist enzyme
In this educational post, I introduce our thyroid hormone conversion enzyme “deiodinase type 1” (D1) in the personality of “The philanthropist” as I draw on many scientific articles. Of course, D1 is a genderless enzyme. I am personifying “her” in… Read More ›
-
The 7 lessons of the thyroid hormone deiodinases
The recent post “Thyroid hormone journey: Metabolism” is an educational compendium of diagrams, tables and bullet lists that highlight key lessons from the past five decades of thyroid science. It’s like a booklet in a blog post. The article concluded… Read More ›
-
Thyroid hormone journey: Metabolism
As one follows the thyroid hormone journey through the human body, at a crucial stage inside many of our cells, a beautiful and complex cascade transforms our thyroid hormones. Three deiodinase enzymes, types 1, 2 and 3 (D1, D2, D3),… Read More ›
-
Finkler, 1959: Liothyronine as a replacement for thyroid therapy
One of Thyroid Patients Canada’s values is to bring to light little-known aspects of the history of thyroid therapy so that it can open minds about future possibilities. The history of L-T3 (Liothyronine) monotherapy brings to light the flexibility and… Read More ›
-
Thyroid Patients Canada: Looking back on 2020, entering 2021
The year 2020 has been a productive year for our organization of thyroid patients and our website, despite the challenges we all faced on a global scale. In this post, HIGHLIGHTS: I’ll briefly mention our organizational milestones of the year…. Read More ›
-
Christmas 2020: Hope and cheer for thyroid patients
It’s been quite a year, so we send you good cheer. This season may be a socially-distanced experience for many of you, but still, you are not alone. We’re stronger together. We’re going to keep advancing thyroid science & policy,… Read More ›
-
Ingbar and Braverman’s historic study of LT4 monotherapy
As part of my post on “The thyroid gland is a T3 shield,” I reviewed a research article by Ingbar and team from 1982. Wow. What a treasure. The title of this article is “Elevated serum thyroxine concentration in patients… Read More ›
Featured Categories
Therapy paradigms ›
-
Mimicry: The idol of T3-T4 combo therapy 2004-2014
September 10, 2020
-
The foundations of synthetic T3-T4 therapy in the 1990s
September 1, 2020
-
Four definitions of thyroid status
March 28, 2020
-
Biochemical bigotry: Enforcing normalized thyroid lab results
February 15, 2020
-
Relational Stability, part 4: The new thyroid paradigm
December 16, 2019
Research Reviews ›
-
Ingbar and Braverman’s historic study of LT4 monotherapy
December 21, 2020
-
Prevalence rates for 10 chronic disorders at various FT4, TSH and FT3 levels
October 21, 2020
-
Japanese thyroid scientists examine symptoms in relation to FT3 and TSH
March 11, 2020
-
Relational Stability, part 3: Shifting TSH-T4-T3 relationships
December 16, 2019
-
Relational Stability, Part 2: Normality of TSH and thyroid hormones
December 15, 2019
Testing policy ›
-
How can clinical biochemists help or harm thyroid patients?
March 2, 2020
-
Survey: Canadian Thyroid Testing Tips & Challenges
December 19, 2019
-
In 1981, Canadian physicians argued T3 was the best test in thyroid therapy
December 10, 2019
-
2019 ATA article engages in patient-blaming and doctor-shaming
December 2, 2019
-
Caution: Doctors perform T3-ectomies without our consent
November 23, 2019